[HTML][HTML] The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study
Diabetologia, 2017•Springer
Aims/hypothesis Chronic hyperglycaemia, as measured by HbA 1c levels, is a major risk
factor for atherosclerosis and cardiovascular disease (CVD) in type 1 diabetes. Our aim was
to describe the degree to which the effect of HbA 1c on the risk of CVD is mediated by its
effect on traditional risk factors over time, and how these mediation pathways change over
time. Methods The DCCT and its observational follow-up study, the Epidemiology of
Diabetes Interventions and Complications (EDIC), followed 1441 participants for a mean of …
factor for atherosclerosis and cardiovascular disease (CVD) in type 1 diabetes. Our aim was
to describe the degree to which the effect of HbA 1c on the risk of CVD is mediated by its
effect on traditional risk factors over time, and how these mediation pathways change over
time. Methods The DCCT and its observational follow-up study, the Epidemiology of
Diabetes Interventions and Complications (EDIC), followed 1441 participants for a mean of …
Aims/hypothesis
Chronic hyperglycaemia, as measured by HbA1c levels, is a major risk factor for atherosclerosis and cardiovascular disease (CVD) in type 1 diabetes. Our aim was to describe the degree to which the effect of HbA1c on the risk of CVD is mediated by its effect on traditional risk factors over time, and how these mediation pathways change over time.
Methods
The DCCT and its observational follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC), followed 1441 participants for a mean of 27 years, with periodic measurement of HbA1c and risk factors over time. We assessed the proportion of the HbA1c effect on risk of CVD that was mediated through its effects on systolic BP (SBP), pulse rate, triacylglycerols and LDL-cholesterol (LDLc) levels, and how the proportion mediated changed over time.
Results
The association of HbA1c with CVD outcomes was stable over time, while that of traditional risk factors (SBP, pulse rate, triacylglycerols and LDLc) increased. At 10 years of follow-up, the effect of HbA1c on 10 year CVD risk was minimally mediated by SBP (2.7%), increasing to 26% at 20 years. Likewise, from 10 year follow-up to 20 year follow-up, the proportion of HbA1c effect mediated through pulse rate increased from 6.3% to 29.3%, through triacylglycerols from 2.2% to 22.4%, and through LDLc from 9.2% to 30.7%.
Conclusions/interpretation
As participants age, the predictive association of mean HbA1c on subsequent CVD events is increasingly mediated by its effect on standard risk factors. Thus, management of traditional non-glycaemic CVD risk factors may have increasing benefits in an ageing type 1 diabetes population with longstanding hyperglycaemia.
Trial registration: ClinicalTrials.gov NCT00360893 and NCT00360815.
Springer